Great Panther Mining Ltd (NASDAQ:SBBP) continues to move up in the pre-market session on Friday after soaring 12.50% in yesterday’s trading session.
Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome
- announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,020,393 entitled, “Methods of Treating Disease with Levoketoconazole” which covers a method of treating Cushing’s syndrome patients with RECORLEV® (levoketoconazole) who also take metformin for Type 2 diabetes. The term of the U.S. patent will expire on March 2, 2040.
- This will be the third patent issued in the U.S. relating to RECORLEV. The first, U.S. Patent No. 9,198,906, covers methods of reducing C-reactive protein levels and systemic inflammation through administration of a once-daily dose of RECORLEV and will expire on December 29, 2030. The second, U.S. patent No. 9,918,984, covers methods of treating Cushing’s syndrome with levoketoconazole and will expire on January 10, 2026.
- RECORLEV is an adrenal steroidogenesis inhibitor with a New Drug Application that is currently under review by the U.S. Food and Drug Administration for the treatment of endogenous Cushing’s syndrome.
Market Action
As of 7:23, SBBP stock went up 1.01% to $3. The stock has traded 5.5K so far in the pre-market session.
 Gets New Patent){kind=link}